Effect of vaccinating lambs against pneumonic pasteurellosis under New Zealand field conditions on their weight gain and pneumonic lung lesions at slaughter

In a field trial, 9174 lambs from seven commercial sheep flocks with a history of subclinical pneumonia were either vaccinated with Ovipast Plus (Intervet) or given a placebo by systematic random allocation; they were vaccinated twice at an interval of four to six weeks and grazed on pasture in the same paddocks. They were weighed at the first vaccination, 11 and 23 weeks later, and one to three days before they were slaughtered. The extent of the pneumonic lesions in their lungs was scored visually postmortem. A subset of pneumonic lung samples was examined bacteriologically and histopathologically. There were no statistically significant differences between the pneumonic lesions at slaughter or the mean average daily weight gains of the vaccinated and placebo-treated lambs between 11 and 23 weeks or between first vaccination and slaughter. The vaccinated lambs had a lower mean daily gain between first vaccination and 11 weeks. The extent of pneumonic lesions at slaughter was negatively correlated with the mean daily gain between first vaccination and slaughter. There were no significant differences between the frequency of isolation of Mannheimia (Pasteurella) haemolytica and Pasteurella trehalosi or the histopathological classification of disease between pneumonic lung samples from the placebo-treated and vaccinated lambs.     

Varying effects of infections with Mycoplasma hyopneumoniae on the weight gain recorded in three different multisource fattening pig herds

Pigs in three specialized fattening herds were studied with respect to the effect of infection with Mycoplasma hyopneumoniae on weight gain. Individual pigs were weighed four times at 4-week intervals during the fattening period and their daily weight gain over the rearing period was calculated. A blood sample was collected on each weighing occasion and analysed for the presence of antibodies to M. hyopneumoniae. The lungs of the principals were inspected at slaughter and the extent of pneumonic lesions was registered by a specially developed technique that has been proven to warrant a high degree of repeatability. No serum antibodies to M. hyopneumoniae were detected in one of the herds, and no pneumonic lesions were recorded at slaughter in that herd. In the other two herds, the prevalence of pigs with serum antibodies to M. hyopneumoniae increased from 6 to 54% and from 31 to 81%, respectively, during the fattening period. The prevalence of pneumonic lesions at slaughter in these herds was higher the later the pigs seroconverted. On the other hand, the extension of the lung lesions tended to be higher among pigs that seroconverted early during the rearing period. Infections with M. hyopneumoniae acquired early during the rearing, presumably strengthened by secondary infections and environmental errors, was found to decrease the daily weight gain of the pigs. However, even non-complicated M. hyopneumoniae infections acquired late in the fattening period were associated with reduced daily weight gain. That growth reduction was estimated to be at least 60 g (about 6%) after adjusting for herd, pen, initial weight and sex.     

Pneumonia in pigs induced by intranasal challenge exposure with pseudorabies virus and Pasteurella multocida

The interaction between pseudorabies virus (PRV) and Pasteurella multocida was investigated to determine whether single or combined infections result in pneumonia in 6- to 7-week-old pigs. The effect of the PRV-P multocida challenge exposure on feed consumption, rate of gain, and extent of pneumonic lesions appeared dependent on the PRV dose; however, pneumonic lesions were of bacterial pneumonia. Pigs inoculated with a virulent strain of PRV plus P multocida developed severe pneumonia, whereas pigs given PRV only did not develop pneumonia. Modified-live PRV vaccine had no effect on the occurrence of pneumonia. Average daily gain was most depressed in pigs given the highest dose of virulent PRV plus P multocida.     

Host determinants of pneumonia in slaughter weight swine

A prospective cohort study was undertaken in a farrow-to-farrow swine herd to describe patterns of pneumonia, and to identify host risk factors associated with the extent of pneumonic lesions in 2 weight groups of slaughter swine. The risk of coughing and pneumonic lesions increased with increasing age of pigs within the herd (P less than 0.0001). The age-specific prevalence of pneumonic lesions was low (2.7%) in pigs less than 16 weeks old at slaughter, but increased rapidly when pigs were between 16 and 22 weeks old (8.6 to 67.9%). After 22 weeks, the prevalence remained relatively constant at about 80%. Associations between possible risk factors and pneumonia were investigated by use of multiple-regression models. Age at weaning (less than 24 days) and birth weight (less than 1 kg) exerted small, but significant (P less than 0.002), effects on the extent of pneumonic lesions in pigs slaughtered at 30 to 50 kg live weight. For pigs slaughtered at 90 to 110 kg, pneumonic lesions were more extensive (P = 0.007) in pigs sired by Yorkshire boars than pigs sired by non-Yorkshire sires (Duroc, Hampshire, Chester White, or American Spotted). Other host factor variables including weaning weight and clinical diseases (atrophic rhinitis, diarrhea, and arthritis) were not associated with pneumonia extent in either weight group. Higher pneumonia percentages were also associated with reduced growth rates in the grower/finisher phase. Pigs sired by Yorkshire boars grew significantly (P less than 0.0001) more slowly from entry into shed 2 (mean, 38 kg) until about the time of exit (mean, 92 kg) than pigs sired by other breeds (747 g/d and 795 g/d, respectively).     

Evaluation of the effects of enzootic pneumonia in pigs on weight gain and days to slaughter under New Zealand conditions

The effects of enzootic pneumonia on average daily weight gain and number of days taken to reach slaughter weight was studied in 333 bacon-weight pigs. Each 1% of lung volume affected by enzootic pneumonia was shown to reduce average daily gain by 2.2 grams and increase the numbers of days to slaughter by 0.61 days. The cost of these reductions in performance was calculated to be about NZD 1 for each 1% of lung affected.     

The effect of chronic non-progressive pneumonia on weight gain of pasturefed lambs

The liveweight gains and carcass weights of 40 lambs grazed under pastoral conditions were compared with those of a similar group with chronic non-progressive pneumonia which had been induced by intranasal inoculation of an aerosol of homogenised pneumonic lung at about 120 days of age. Half the lambs from each group were killed 30 days post-inoculation following rotational grazing on high quality pasture. At this time the pneumonic lambs had a mean liveweight gain of 1.74 kg less than the controls. The remainder were slaughtered at 60 days, when drier conditions prevailed, by which time the difference in mean liveweight had increased to 2.19 kg. During the second period, four of the severely affected lambs lost weight. A significant linear relationship was found between liveweight gain and the extent of the pneumonic lesions which indicated that a reduction of nearly 1 kg/month could be expected for every 10% of the lung surface area affected. Carcass weights were reduced by a mean of 1.5 kg over the 60-day period, 1.39 kg of which occurred in the first 30 days.     

The effect of chronic non-progressive pneumonia on weight gain of pasture-fed lambs

The liveweight gains and carcass weights of 40 lambs grazed under pastoral conditions were compared with those of a similar group with chronic non-progressive pneumonia which had been induced by intranasal inoculation of an aerosol of homogenised pneumonic lung at about 120 days of age. Half the lambs from each group were killed 30 days post-inoculation following rotational grazing on high quality pasture. At this time the pneumonic lambs had a mean liveweight gain of 1.74 kg less than the controls. The remainder were slaughtered at 60 days, when drier conditions prevailed, by which time the difference in mean liveweight had increased to 2.19 kg. During the second period, four of the severely affected lambs lost weight. A significant linear relationship was found between liveweight gain and the extent of the pneumonic lesions which indicated that a reduction of nearly 1 kg/month could be expected for every 10% of the lung surface area affected. Carcass weights were reduced by a mean of 1.5 kg over the 60-day period, 1.39 kg of which occurred in the first 30 days.     

A model for the induction of Pasteurella multocida type-A pneumonia in pigs.

A model for the induction of pneumonia caused by Pasteurella multocida type-A was developed. Anesthetized pigs were dosed intratracheally with 10(10) colony forming units of P. multocida type-A suspended in a total dose of saline based on the pig's body weight (8 mL/kg). A severe bronchopneumonia was present when the treated pigs were euthanized seven days postinfection. The mean percentage of pneumonic lesions in the treated pigs, as determined by morphometric measurement, was 14.03 +/- 7.01 (X +/- SD). In contrast, in the control pigs, the mean percentage of pneumonic lesions was 0.59 +/- 0.52. For the treated pigs during the period following induction of pneumonia, weight gain and feed intake were reduced significantly (p less than 0.05) compared to the controls. It was shown that severe pneumonia could be induced without the use of other infectious agents, which could potentially confound the experimental model.     

Treatment of experimental enzootic pneumonia of the pig by norfloxacin or its 6-chloro analogue

The 6-chloro analogue of norfloxacin (compound A) administered continuously in the feed at 400 ppm for 21 days markedly reduced the extent and activity of pneumonic lesions in pigs with pneumonia induced experimentally with an homogenate of pneumonic lung and broth cultures of Mycoplasma hyopneumoniae. Norfloxacin at 100 ppm or compound A at 200 ppm in the feed did not reduce the extent of lung lesions, although half the pigs treated with norfloxacin had lesions which appeared histologically to be healing. M hyopneumoniae was detected either by culture or immunofluorescence in the lungs of 60 per cent of the pigs treated with compound A at 400 ppm compared with all the pigs in the other groups. These results were related to the amount of drug in the lungs and body fluids during therapy. Only compound A at 400 ppm produced concentrations in the lungs and bronchial secretions exceeding the minimum inhibitory concentration against M hyopneumoniae. Mycoplasmacidal concentrations were not reached either in the lungs or bronchial secretions which might account partly for the frequent detection of M hyopneumoniae in the lungs after treatment. Drug resistance did not appear to be responsible for the persistence of M hyopneumoniae in vivo since the M hyopneumoniae isolates from the pigs after therapy were sensitive in vitro to both quinolones. As daily weight gain and feed-conversion efficiency improved in all groups of treated pigs compared with the controls, these effects were probably unrelated to the antimycoplasmal activities of the two quinolones.     

Pneumonic lesions in lambs in New Zealand: patterns of prevalence and effects on production

AIM: To describe temporal and spatial patterns of the prevalence of pneumonia in lambs in three regions of New Zealand, and determine effects on liveweight gain. METHODS: A longitudinal study was conducted in 1999- 2000 on 14 commercial sheep farms, five from the Southland region of the South Island, and five from the King Country and four from the Northland regions of the North Island. Pneumonia was known to be a problem in lambs on all farms selected. On each farm, 400 lambs were randomly selected at weaning and allocated at random to one of two groups (Groups I and II). Lambs in both groups were weighed at 4-weekly intervals. The extent of pneumonic lesions in lungs was scored visually at slaughter in 40 randomly selected lambs after each weighing (Group I). Lambs in Group II were selected for slaughter by the farm manager on a commercial basis of liveweight and body condition, then assessed for pneumonic lesions. RESULTS: Prevalence of extensive pneumonic lesions (>/=10% lung surface area affected) increased from December to March from 1.4 to 10.1% lambs in Southland (n=1,917), 1.2 to 25.7% in the King Country (n=1,831), and 4.7 to 21.4% in Northland (n=1,485). Overall, 42.3% of lambs in both groups had pneumonic lesions (n=5,233) and in 15.1% of these, >/=5% of the lung surface area was affected. Daily weight gain in the month prior to slaughter was reduced in lambs for which >/=20% lung surface area was affected in Group I (p<0.05) but not in Group II. CONCLUSIONS: The association between pneumonic lesions and reduced weight gain was highly significant in lambs from Group I, but not from Group II. Thus, pneumonia had a negative impact on weight gain, and selection by farmers of lambs for slaughter counteracted this association in lambs from Group II. CLINICAL RELEVANCE: Pneumonia occurs commonly as a subclinical disease in lambs in New Zealand. It has no public health significance and is not recorded at slaughter plants nor reported to farmer clients. Effects of the disease on daily weight gain of lambs is considerable and costly for lamb producers.     

Association of growth performance with atrophic rhinitis and pneumonia detected at slaughter in a conventional pig herd in Hungary

The influence of atrophic rhinitis (AR) and pneumonia on growth performance was assessed in a conventional farrow-to-finish pig farm affected by both diseases. All tested pigs (n = 138) were individually weighed at birth, at weaning, at moving to the growing/finishing unit, and at slaughtering. The extent (grade) of turbinate atrophy and lung consolidation attributable to pneumonia was determined in each pig at slaughter. A negative correlation was found between birth weight and the prevalence of nasal lesions at slaughter, suggesting that pigs born with smaller weight may be more susceptible to AR. The growth performance of the pigs also showed a negative correlation with the degree of turbinate atrophy. In the nursery period, the average daily gain (ADG) of pigs with moderate/severe turbinate atrophy was 13.3% lower than that of animals with healthy snouts. In the finishing period, pigs with mild AR lesions had an ADG reduction of 6.2%, while pigs with severe AR lesions had a significant, 9.4% reduction in ADG as compared to the AR-free pigs. The extent of weight gain reduction over the whole life cycle was very similar (approximately 6%) in the pigs having either AR or pneumonia alone. In those pigs where both respiratory diseases were present, their effects seemed to be added up (11.5%); however, nasal lesion scores and percentage of lung consolidation did not show statistically apparent interactive effects on growth performance.     

Performance measured in pigs with pneumonia and housed in different environments

During an investigation of poor growth performance, rate of weight gain and feed efficiency were studied in pigs with pneumonia. During the study, pigs either were housed in an improved environment or remained at their home farm. In both environments, rate of gain tended to decrease in association with increasing severity of pneumonia. When pigs with similar extent of lung lesions were compared, growth performance of pigs housed in the improved environment was better than that of pigs on the home farm. However, growth performance of pigs with pneumonia affecting greater than 20% of lung tissue was equally poor in either environment. When type of housing and extent of pneumonia were included in a model for analysis of variance, housing had a highly significant (P = 0.003) effect on rate of gain, and pneumonia had a nonsignificant effect.     

Measurement of conchal atrophy and pneumonic lesions and their association with growth rate in commingled feeder pigs

A group of 85 commingled feeder pigs was fed on a totally confined feeding floor until slaughter. Mean daily weight gain was calculated for each pig. At slaughter, the nose of each pig was cross-sectioned and scored for conchal atrophy by use of 2 methods. One method ascribed a score based on a linear measurement of the distance between the ventral scroll of the ventral conchae and the ventral floor of the nasal cavity. The other method ascribed a score based on a subjective evaluation of the degree of conchal degeneration according to previously published guidelines. The amount of pulmonary consolidation attributable to pneumonia was also estimated for each pig. Association was not found between growth rate and conchal atrophy, as determined by linear measurement scores. A negative correlation existed between growth rate and conchal atrophy, as determined by subjective evaluation scores. Pigs with extensive pneumonic lesions (consolidation of 20 to 30% of total lung volume) grew slower than pigs with milder pneumonic lesions. Results of this study indicate that subjective evaluation scores of conchal atrophy may be more useful in predicting growth rate than are linear measurement scores.     

Relationship to growth performance of pneumonia and atrophic rhinitis lesions detected in pigs at slaughter among four seasons.

A commercial swine herd was selected for study, because pigs at slaughter repeatedly had lung lesions consistent with enzootic pneumonia and had snout lesions typical of atrophic rhinitis. Pigs born during various seasons of the year were allotted to 4 investigations and were evaluated from birth to slaughter. Individual lungs and snouts were identified and collected at the slaughter plant and later examined for gross lesions of bronchopneumonia and atrophic rhinitis, respectively. Each lesion was scored, and the following comparisons were made within investigations: prevalence and mean scores for lung lesions; prevalence and mean grades for snout lesions; correlations between lung lesion scores and growth indicators; correlations between snout lesion grades and growth indicators; and correlations between lung lesion scores and snout grade scores. Included in the growth indicators were average daily gain during the growing phase, average daily gain during the finishing phase, average daily gain during growing and finishing phases, and days to attain 104.5 kg of body weight. Prevalence of lung or snout lesions, mean values for lung lesion scores, mean values for snout lesion grades, and mean values for the various growth indicators were tested for statistical differences among the 4 investigations. Prevalence of lung lesions was highest (96%) for winter-slaughtered and lowest (81%) for autumn-slaughtered pigs. Mean scores for lung lesions were 7% (summer), 5% (autumn), 9% (winter), and 16% (spring). Prevalence of snout lesions was highest (85%) for spring-slaughtered pigs and lowest (42%) for autumn-slaughtered pigs.(ABSTRACT TRUNCATED AT 250 WORDS)     

Relationship of growth performance to pneumonia and atrophic rhinitis detected in pigs at slaughter

Three commercial swine herds were selected for study, because pigs at slaughter consistently had lung lesions typical of bronchopneumonia and snout lesions consistent with atrophic rhinitis. Pigs were reared in the conventional system for each herd except that they were identified at birth and weighted at various intervals. At slaughter, individual pig lungs and snout were examined for lesions of pneumonia and atrophic rhinitis, respectively. Lesions were scored and correlated with growth indicators for each pig. Included in the growth indicators were: average daily gain (growing phase), average daily gain (finishing phase), average daily gain (total), and days to reach 104.5-kg body weight. Additionally, for each pig, scores for lung lesions were correlated to grades for snout lesions. Three correlation coefficients for measurements of pigs within herd B were significant and included days to 104.5-kg body weight and grades for snout lesions, -0.15 (P less than 0.02); average daily gain (finishing) and grades for snout lesions, 0.17 (P less than 0.01); and average daily gain (total) and grades for snout lesions, 0.16 (P less than 0.01). Contrary to findings in other investigations, pigs that attained market weight at the youngest age did not have the lowest score for lung lesions, the lowest grade for snout lesions, or the least extensive or severe lesions. Combining data from all 3 herds, the mean scores for lung lesions and mean grades for snout lesions decreased significantly (P less than 0.05) as the age of pigs at slaughter increased. All other statistical correlations were not significant.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of atrophic rhinitis on growth rate in Illinois swine herds

Influence of atrophic rhinitis (AR) on mean daily weight gain (MDG) was studied in hogs randomly selected from 7 farrow-to-finish herds in Illinois. Herds were selected to obtain a wide range of clinical signs and lesions of the disease; thus, prevalence of clinical signs of AR in finishing hogs ranged from 0% to 20% among herds, and in hogs examined at slaughter the proportion of hogs with turbinate lesions ranged from 5% to 92%. None of the herds investigated had any obvious problems with pneumonia; nevertheless, hogs with moderate to severe pneumonic lesions were excluded from the study, to minimize any combined effect of AR and pneumonia. In 3 herds, MDG in AR-free pigs was 15% to 18% better than in pigs with severe AR lesions. Prevalence of clinical signs ranged from 5% to 20%, and of turbinate lesions, from 66% to 92%. In 4 herds in which MDG appeared to be unaffected by AR, prevalence of clinical signs of the disease ranged from 0% to 5%, and of turbinate lesions, from 5% to 74%. No consistent pattern of influence on AR lesions was found for bacterial infections, as determined by culturing of nasal swab specimens on MacConkey agar and blood agar.     

The association between pneumonia and atrophic rhinitis in slaughter weight Swine

Four hundred and sixty-two pigs from 37 herds were examined at slaughter for the presence and extent of turbinate atrophy and pneumonia. Turbinate atrophy was scored by measuring the mm space between the turbinate bone and the floor of the nasal cavity on both sides of the nasal septum. The total percentage of pneumonic involvement for each lung was evaluated by scoring the percentage of each lobe that was consolidated.

There was a low, positive correlation between individual scores of turbinate atrophy and the associated percentage of lung involved with pneumonia (r = + 0.177; p < 0.001). There was a postive correlation between the herd mean turbinate atrophy score and the herd mean percentage pneumonia score (r = + 0.515; p = 0.001).

The age at slaughter was known for 95 pigs from four herds and was not significantly correlated with the mm of turbinate atrophy, or the percentage of pneumonia.

     

An Epidemiologic and Economic Study of Respiratory Diseases in Two Conventional Danish Swine Herds. I: Prevalence of Respiratory Lesions at Slaughter and Their Effects on Growth

A total of 578 slaughter pigs from 2 Danish conventional farrow-to-finish operations (Herds A and B) were followed from an age of 14 days to slaughter. Pigs were weighed at 3 weeks intervals and at slaughter and an extended post mortem examination of the plucks was done. Comparison of growth rates in pigs with and without specific types of lesions by the t-test and those with multiple lesions with regression models demonstrated that Mycoplasma-like pneumonia, complicated pneumonia, anterio-ventral pleuritis, fissures and atrophic rhinitis significantly reduced mean daily gain and increased the time required to reach slaughter weight. The total impact of the lesions in Herd A was an estimated reduction in mean daily gain of 27 grams and a 2 day increase in the interval from 14 days of age until slaughter (MDG14). Decreases in MDG14 in Herd B were more substantial, 98 grams and 16.7 days. Reductions in mean daily gains during the interval from the fourth weighing until slaughter were 31 grams in Herd A and 137 grams in Herd B. Chronic dorso-caudal and parietal pleuritis, without other lesions present, had no significant adverse effects on growth rates in either herd. Interactions between lesions did not significantly alter the estimates. The R² values obtained for the regression models showed that the presence, absence or extent of lesions at slaughter explained only 13-27% of the variations in growth rates in the 2 herds.     

Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine

The efficacy of tilmicosin administered in the feed to control Actinobacillus pleuropneumoniae infections in pigs was evaluated through a multisite, multitrial study. For each of 6 trials, 48 pigs (stratified by weight and sex) were randomly assigned to 6 to 8 pens. Medicated feed containing tilmicosin (200 g/t) and unmedicated feed were randomly assigned at the pen level and were provided ad libitum from day −7 to trial termination (day 14). Seeder pigs (inoculated intranasally with A. pleuropneumoniae serotype 1 and showing signs of clinical disease) were introduced to each pen on day 0. Rates of death, gross lesions, and culture of A. pleuropneumoniae at necropsy, clinical scores, average daily gain in weight, and average body temperature were compared between the medicated and unmedicated pigs. Compared with the unmedicated pigs, significantly fewer (P < 0.05) pigs given tilmicosin had lesions typical of A. pleuropneumoniae or had A. pleuropneumoniae isolated from their tissues at necropsy. Together with a significant reduction (P < 0.05) in the average percentage of pneumonic lung involvement (both visually and by weight), there were reductions in the numbers of pigs with moderate and severe pneumonic lung lesions and with A. pleuropneumoniae associated mortality. With tilmicosin treatment, the average daily weight gain, daily temperature, abdominal appearance, attitude, and respiration were also significantly better (P < 0.05). The results of this study demonstrate the in vivo effectiveness of tilmicosin (200 g/t) in controlling pleuropneumonia among swine experimentally infected with A. pleuropneumoniae.     

Evaluation of tulathromycin for the treatment of pneumonia following experimental infection of swine with Mycoplasma hyopneumoniae

Tulathromycin was evaluated in the treatment of pneumonia in weaned pigs inoculated intranasally with Mycoplasma hyopneumoniae. Five days postchallenge, the pigs were randomized to treatment with a single IM administration of saline, a single IM administration of tulathromycin (2.5 mg/kg; day 0), or three IM administrations of enrofloxacin (5.0 mg/kg; days 0, 1, 2). Pigs were necropsied on day 12 or 13. Unchallenged controls remained healthy with no lung pathology. Compared with saline, coughing, mean lung lesion score, and proportional lung weight were significantly reduced and weight gain was significantly greater for tulathromycin-treated pigs (P < .05). Compared with enrofloxacin, there were no significant differences in proportional lung weight or weight gains, but coughing and lung lesion scores were greater for tulathromycin-treated pigs (P < .05). Tulathromycin was effective in the treatment of pneumonia following experimental infection with M. hyopneumoniae.